PharmAthene, Inc. Reports Third Quarter 2013 Financial and Operational Results
Published: Nov 08, 2013
ANNAPOLIS, Md., Nov. 7, 2013 /PRNewswire/ --
-- On track to commence SparVax(R) Phase 2 clinical trial
-- Presented new SparVax(R) anthrax vaccine data at the 2013 Bacillus-ACT International Conference and the 53rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Help employers find you! Check out all the jobs and post your resume.